HBL Hadasit Bio Holdings Ltd
TASE:HDST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HBL Hadasit Bio Holdings Ltd
TASE:HDST
|
IL |
|
D
|
DuksanHiMetal Co Ltd
KOSDAQ:077360
|
KR |
|
Supply Network Ltd
ASX:SNL
|
AU |
|
X
|
Xero Ltd
OTC:XROLF
|
NZ |
|
Mullen Automotive Inc
NASDAQ:BINI
|
US |
|
Mahindra EPC Irrigation Ltd
NSE:MAHEPC
|
IN |
|
Minda Corporation Ltd
NSE:MINDACORP
|
IN |
|
I
|
Infobird Co Ltd
NASDAQ:IFBD
|
CN |
|
Contango Holdings PLC
LSE:CGO
|
UK |
|
D
|
Dongbang Transport & Logistics Co Ltd
KRX:004140
|
KR |
|
EMX Royalty Corp
XTSX:EMX
|
CA |
HBL Hadasit Bio Holdings Ltd
HBL- Hadasit Bio-Holdings Ltd. engages in investments in research and development companies in the medical and biotechnology sectors. The Company’s subsidiaries enable research and development and promote intellectual property (IP) to the medical and biotechnological industries. The firm together with its strategic partners, has established a number of start-up companies, and is assigned to commercialize that IP either through granting a product license to biotechnological or pharmaceutical companies or via the creation of a subsidiary which operates in the premise of HMO. Hadasit is equipped with resources and capabilities required for composing and conducting the pre-clinical services and clinical studies, establishing start-up companies, offering product licensing and providing international consulting services. The Company’s framework serves to address investment in early-stage biotechnological star-ups, by distributing both risk and success amongst a number of companies.
HBL- Hadasit Bio-Holdings Ltd. engages in investments in research and development companies in the medical and biotechnology sectors. The Company’s subsidiaries enable research and development and promote intellectual property (IP) to the medical and biotechnological industries. The firm together with its strategic partners, has established a number of start-up companies, and is assigned to commercialize that IP either through granting a product license to biotechnological or pharmaceutical companies or via the creation of a subsidiary which operates in the premise of HMO. Hadasit is equipped with resources and capabilities required for composing and conducting the pre-clinical services and clinical studies, establishing start-up companies, offering product licensing and providing international consulting services. The Company’s framework serves to address investment in early-stage biotechnological star-ups, by distributing both risk and success amongst a number of companies.
